Add BrightSurf on Google Email

A rare case of Parkinson's disease reveals molecular changes in platelets during disease progression

A rare case of early-onset Parkinson's disease reveals molecular changes in platelets associated with disease progression. The study identified changes in gene expression in platelets, including those involved in mitochondrial function and protein synthesis, providing insights into molecular processes involved in disease progression.

SourceGermans Trias i Pujol Research Institute·JournalMovement Disorders·TypeCase study·DateOct 30, 2026

Chinese Neurosurgical Journal review explores neurological considerations for gender dysphoria care

A Chinese Neurosurgical Journal review clarifies neuroanatomical variations, neurological and neurosurgical risk factors, and perioperative considerations for gender dysphoria treatment. The review aims to improve neurosurgeon knowledge and holistic care for individuals with gender dysphoria.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeLiterature review·DateOct 28, 2026

How dismissed symptoms can push patients to breaking point

A new study reveals concerns about misdiagnosis and stigma in autoimmune diseases with functional neurological disorder (FND), highlighting the need for better communication and holistic care. Patients and clinicians often see things differently, and poor explanations can lead to feelings of guilt, shame, and suicidal thoughts.

SourceUniversity of East Anglia·JournalRheumatology International·TypeSurvey·DateOct 26, 2026

Researchers develop new AI tool to better predict stroke risk

Researchers developed an AI tool that analyzes genetic data to identify risk factors for stroke, which can lead to personalized risk assessments and targeted prevention strategies. The tool was more accurate than previous genetic risk tools in distinguishing people who had suffered a stroke from those who had not.

SourceUniversity of Technology Sydney·JournalComputer Methods and Programs in Biomedicine·TypeComputational simulation/modeling·DateOct 15, 2026

University of Cincinnati study shows proof-of-concept for hydrocephalus gene therapy

Researchers at the University of Cincinnati have developed a proof-of-concept gene therapy that targets and reduces the production of cerebrospinal fluid, potentially providing a minimally invasive treatment for hydrocephalus. The therapy uses an adeno-associated virus to deliver therapeutic genetic material into a patient's cells, wit...

SourceUniversity of Cincinnati·JournalFluids and Barriers of the CNS·TypeExperimental study·DateOct 14, 2026

Study links experimental stroke protection to the brain’s backup blood vessels

A preclinical study from Duke University researchers suggests that the effectiveness of an experimental approach to limiting stroke-related brain injury may depend on the brain's collateral circulation. In mouse models of ischemic stroke, the researchers found that AZD1390, a brain-penetrant inhibitor of the ATM kinase, reduced acute i...

SourceScience Exploration Press·JournalFerroptosis and Oxidative Stress·TypeExperimental study·DateOct 12, 2026

Epidemiology of hypoxic-ischemic encephalopathy after cardiopulmonary resuscitation in intensive care units: a nationwide database study in China

A nationwide database study in China found that hypoxic-ischemic encephalopathy after CPR in ICUs accounted for 1.41% of all ICU admissions, with a high mortality rate of 60.65%. Regional variations in incidence and mortality rates were observed, with higher mortality among patients with multiple comorbidities and complications.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeData/statistical analysis·DateOct 12, 2026

New device targets nerve signals to treat cancer-related wasting, moving to first human trial

A new device has been approved for a first human trial to treat cancer-related wasting, a severe and progressive syndrome affecting many patients with advanced cancer. The device, OnVagus, delivers noninvasive electrical stimulation to modulate the vagus nerve, aiming to preserve strength and quality of life during treatment.

SourceTerasaki Institute for Biomedical Innovation·TypeRandomized controlled/clinical trial·DateOct 7, 2026

The brain on the edge of chaos. What keeps our vision under control?

Researchers developed a model of the primary visual cortex, introducing feedback mechanisms to constrain chaos and reduce neural activity variability. The model showed a 93 percent reduction in variability, allowing the brain to remain flexible while reliably processing visual information.

SourceInstitute of Physical Chemistry of the Polish Academy of Sciences·JournalJournal of Computational Neuroscience·TypeExperimental study·DateSep 22, 2026

Johns Hopkins researchers break neuroimaging time barrier to reveal new clues about brain disease

Researchers at Johns Hopkins Medicine have developed a new approach to brain imaging that enables continuous monitoring of brain activity and disease progression for over 24 hours in freely moving mouse models. The cloud-based miniaturized microscope, CloudScope, allows scientists to access live imaging data remotely, providing a more ...

SourceJohns Hopkins Medicine·JournalNature Methods·DateSep 10, 2026

Efficient and safe peripheral macrophage replacement by Mr BMT expands the therapeutic potential of microglia replacement beyond the CNS

Researchers from Fudan University developed a strategy to achieve efficient engraftment of macrophages in peripheral organs using Mr BMT, a technique that replaces microglia in the CNS. The study shows that Mr BMT preserves tissue homeostasis and innate immune response, with durable macrophage replacement lasting at least 9 months.

SourceFudan University·JournalAdvanced Science·TypeExperimental study·DateSep 4, 2026

Why some stroke patients fare better than others

A new study from the University of Colorado Boulder reveals how the brain's defense mechanism can backfire, forming micro-clots that damage tissue after the original clot is gone. This phenomenon, known as no reflow, affects up to 50% of stroke patients and can lead to long-term disability or death.

SourceUniversity of Colorado at Boulder·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 2, 2026